Evidence map›Paper›PMID 40786069›Full record

ArticleNature synthesis2025

Reactions of a Zn-Zn bond with main group carbene analogues as a prototypical case of reductive addition.

Wenbang Yang, Andrew J P White, Mark R Crimmin

Abstract read
In one paragraph

Article in Nature synthesis, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Article
  3. A Crystalline In(II) Hydride.Journal of the American Chemical Society · 2026
    Article
  4. Article
  5. Breaking Bonds at Tin(II): Reductive or Oxidative Addition?Angewandte Chemie (International ed. in English) · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Wenbang YangMolecular Sciences Research Hub, Imperial College London, London, UK.ORCID 0000-0002-8385-249X
Andrew J P WhiteMolecular Sciences Research Hub, Imperial College London, London, UK.
Mark R CrimminMolecular Sciences Research Hub, Imperial College London, London, UK.ORCID 0000-0002-9339-9182

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Oxidative addition most commonly involves the addition of a substrate to a metal centre. This reaction is fundamental across synthetic chemistry and underpins numerous catalytic methods. In the textbook description of oxidative addition reactions, a net increase in the formal oxidation state of the metal occurs with simultaneous bond breaking at the substrate. The majority of known oxidative addition reactions, however, involve substrates bearing relatively electronegative elements (for example, hydrogen, carbon, nitrogen, oxygen and halogens) and there has been little discussion of how addition processes may fundamentally change if substrates were constructed from more electropositive elements. Here we show that the zinc-zinc bonded complex, Cp*ZnZnCp* (Cp* = pentamethylcyclopentadienyl), which is isoelectronic with dihydrogen, undergoes facile addition to the metal (or semi-metal) centres of a series of main group carbene analogues based on silicon, aluminium, gallium or indium. Reactions proceed with complete breaking of the zinc-zinc bond and an increase in the coordination number of the central metal from two to four. Our analysis suggests that these addition processes are not oxidative, but rather there is likely a continuum of redox outcomes spanning oxidative, redox neutral and reductive. The addition of Cp*ZnZnCp* to silicon(II) provides the most compelling case for a prototypical reductive addition process.

Indexed as

Chemical bondingOrganometallic chemistry

Identifiers

PMID40786069
PMCPMC12334357

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.